Lipoprotein (Lp) [a] consists of a low-density lipoprotein (LDL) like moiety bound to a highly glycosylated apolipoprotein (a) particle and an apolipoprotein B-100 particle linked via a single disulfide bond (Figure 1). Since its discovery in 1963 by Kare Berg, Lp(a) has gone relatively unnoticed in cardiovascular (CV) risk reduction algorithms (1). More recently, greater attention has been afforded to Lp(a) with growing evidence suggesting its causality in the development of atherosclerotic cardiovascular disease (ASCVD), culminating in a recent consensus statement published by the ESC (2).
Author Sub-editor: Dr Pok-Tin Tang Dr Pok-Tin Tang is an ST5 cardiology registrar in the Thames Valley deanery, currently undertaking a period of out of
Author Sub-editor: Dr May Hu Dr May Hu is a cardiology trainee in the North West deanery. She graduated with First Class Honours from the University
Author Sub-editor: Dr Jhiamluka Solano Dr Jhiamluka Solano is a cardiology resident doctor (ST6) in the Yorkshire and Humber Deanery, currently undertaking a DPhil (PhD)
Author Sub-editor: Dr Joshua Rowland Dr Joshua Rowland is a cardiology registrar working in the North West Deanery. He graduated from the University of Manchester
Author Sub-editor: Dr Atmadeep Banerjee Dr Atmadeep Banerjee is an ST4 Cardiology Registrar in the Kent, Surrey and Sussex deanery. He graduated from Calcutta National
